Key result
Cognitive impairment in diabetic patients linked to ~40% higher odds of uncontrolled blood glucose.
Why the study?
Cognitive impairment may hinder effective self-management of cardiovascular disease and worsen cardiovascular risk, but the rates of uncontrolled cardiometabolic risk factors across cognitive levels needed description to identify priority management groups.
Does cognitive impairment increase the rate of uncontrolled blood pressure, blood lipids, and blood glucose in patients with cardiovascular disease?
Does cognitive impairment increase the rate of uncontrolled blood pressure, blood lipids, and blood glucose in patients with cardiovascular disease?
Cognitive impairment is significantly associated with poorer glycemic control in patients with cardiovascular disease, highlighting the need for proactive care and tailored self-management support.
Cognitive impairment was associated with poorer glycemic control; hypothesis-generating and requires prospective confirmation before practice change.
BACKGROUND: Cognitive impairment may hinder effective self-management of cardiovascular disease and lead to worsening cardiovascular risk. AIMS: This study aimed to describe the rate of uncontrolled blood pressure, blood lipids, and blood glucose across different cognitive levels to identify priority groups for managing risk factors in patients with cardiovascular disease. METHODS: A total of 10,707 patients with cardiovascular disease or individuals at high cardiovascular risk were enrolled from Beijing Anzhen Hospital. Cognitive function, assessed using the Montreal Cognitive Assessment (MoCA) scale, was categorized as normal (MoCA ≥ 26) or impaired (MoCA < 26). Logistic regression was used to explore the association between cognitive function and the rates of uncontrolled blood pressure, lipids, and glucose. RESULTS: Among diabetic patients, the rate of uncontrolled blood glucose in those with cognitive impairment was significantly higher in patients with cognitive impairment than in those with normal cognition [hemoglobin A1c ≥ 7%, 65.7% vs. 56.6%, adjusted odds ratio (aOR) (95% confidence interval, 95% CI):1.40(1.21-1.62), P < 0.001]. The rate of uncontrolled blood pressure and blood lipids were slightly higher in cognitive impairment than normal cognition, however, the differences were not statistically significant [systolic blood pressure(SBP) ≥ 130mmHg and/or diastolic blood pressure(DBP) ≥ 80mmHg, 74.6% vs. 70.5%, aOR(95% CI):1.07 (0.96-1.20), P = 0.206; SBP ≥ 140mmHg and/or DBP ≥ 90mmHg, 45.4% vs. 40.0%, aOR(95% CI):1.08(0.98-1.91), P = 0.125; poor blood lipids management, 72.2% vs. 70.5%, aOR (95% CI):1.00(0.89-1.13), P = 0.994]. CONCLUSIONS: In this cross-sectional study, a significant association was observed between cognitive impairment and an unfavorable cardiovascular risk profile. This may reflect challenges in self-management and underscores the need for proactive care.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2025) studied this question. In diabetic patients, uncontrolled blood glucose was 65.7% in those with cognitive impairment vs. 56.6% in those with normal cognition (aOR 1.40, P < 0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: